Latest

Acurx Pharmaceuticals Announces Publication in ASM Confirming DNA Pol IIIC Inhibitor Pipeline Data Showing Potential Microbiome-Sparing Class Effect

Acurx Pharmaceuticals Announces Publication in ASM Confirming DNA Pol IIIC Inhibitor Pipeline Data Showing Potential Microbiome-Sparing Class Effect

NASDAQ:ACXP Overview Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP), a late-stage biopharmaceutical company developing a new class of antibiotics for serious and life-threatening bacterial infections, announced publication in the ASM (American Society for Microbiology) Microbiology Spectrum journal of results of a study entitled: The effects of novel oral preclinical

Copper Intelligence Inc. Expands Butembo Copper Project with Strategic 3 km Strike Extension Following Continued Exploration Success

Copper Intelligence

Copper Intelligence Inc. Expands Butembo Copper Project with Strategic 3 km Strike Extension Following Continued Exploration Success

OTCID: CUAI Overview Copper Intelligence Inc. announced an expansion of its Butembo Copper Project in the eastern Democratic Republic of Congo through the acquisition of additional highly prospective ground immediately adjoining the company's existing holdings, according to the company. The newly secured tenure extends the company's